The drug "Yarina" describes the instruction as a low-dose contraceptive combined type of drug. The medication has antiandrogenic and antimineralocorticoid properties. It is able to inhibit the secretion of gonadotropic pituitary hormones, inhibit follicular maturation and inhibit the ovulatory process. By increasing the viscosity of cervical mucus when taking the drug, sperm penetration into the uterus is difficult.
The active component, drospirenone, prevents weight gain and other manifestations caused by fluid retention. The substance has an antiandrogenic effect, helps to reduce the secretion of the sebaceous glands and prevents the formation of acne. By preventing estrogen-induced sodium retention, it has a positive effect on the premenstrual state and provides good tolerance. Drospirenone does not prevent ethinyl estradiol-induced increase in the concentration of globulin involved in the binding of sex hormones. This contributes to the inactivation and binding of endogenous androgens.
Describing the drug "Yarina", the instruction indicates normalization, a decrease in the pain of menstruation, a decrease in the intensity of discharge during this period (menstrual). These factors reduce the likelihood of developing iron deficiency anemia.
The medication is recommended for use with acne, hormone-dependent fluid retention in the body, and seborrhea.
Yarina. Instructions for use
The drug is recommended for use over the course of twenty-one days per tablet.
You should select approximately the same time for use. The tablet is recommended to drink with water (a small amount).
It is necessary to start taking from a new package after a seven-day period. During this period, bleeding (menstrual-like) is possible . As practice shows, the discharge begins on the second or third day after taking the last pill. Bleeding may not stop before starting a new package. Continue the use of the drug "Yarina" instruction recommends from a new package, even in the presence of menstrual-like discharge.
If the scheme is followed, bleeding during the seven-day break will begin at about the same time.
Taking the drug can cause vomiting, soreness, engorgement in the mammary glands, discharge from them, a change in libido, body weight, in rare cases, changes in vaginal secretion. In some cases, migraine, mood swings, headache, allergies, fluid retention are noted.
Yarina. Contraindications
The drug is not used for arterial, venous thrombosis, pulmonary artery thromboembolism, deep vein thrombosis, cerebrovascular disorders, myocardial infarction, as well as conditions preceding thrombosis (angina pectoris and other pathologies). The medication is contraindicated in diabetes mellitus, accompanied by vascular complications, in severe forms of liver diseases, including benign and malignant tumors, acute and severe failure. The drug is not prescribed for detected hormone-dependent neoplasms in the genital organs or mammary glands of a malignant nature or with suspicions of them, with vaginal bleeding of an unknown nature, during lactation, with hypersensitivity, acute and severe renal failure.
Another contraindication to taking the drug "Yarina" is pregnancy or suspicion of it.
In case of an overdose, nausea, vaginal bleeding, and vomiting are noted. To alleviate the condition, symptomatic treatment is performed.
Before using the drug, a doctor's consultation is necessary.